What We're Reading: Reforming US Drug Supply Chains; Insurer Coverage of Alzheimer Drug; Data Sharing on Apple Devices
FDA and ASPR issue policy recommendations to reform US pharmaceutical supply chains; insurer coverage implications of the newly approved therapy in Alzheimer disease; Apple announces new health data sharing features.
Biden Administration Issues Policy Recommendations on US Drug Supply Chains
Today, HHS’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and the FDA
How Insurers Plan to Cover Newly Approved Alzheimer Disease Therapy
As the
Apple Announces Health Data Sharing Features
Yesterday, Apple announced new features at the Worldwide Developers Conference that will allow users to opt into sharing their medical records on their devices, letting them choose to share privacy-protected and secured information, such as elevated cholesterol level or physical activity history, with family members or clinicians. As reported by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025